These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 14716821)

  • 1. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity.
    Wan YL; Zheng SS; Zhao ZC; Li MW; Jia CK; Zhang H
    World J Gastroenterol; 2004 Jan; 10(2):195-9. PubMed ID: 14716821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of 4-1BB molecule on peripheral blood T cells in liver transplanted patients and its clinical implication.
    Wan YL; Zheng SS; Jia CK; Liang TB; Huang DS; Wang WL; Li MW; Zhao ZC
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):38-43. PubMed ID: 14599927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8
    Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH
    Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-1BB gene expression in peripheral blood mononuclear cells from orthotopic liver transplant recipients with graft acceptance.
    Wan Y; Zheng S; Jia C; Yang J; Jin X; Zhao Z
    Chin Med J (Engl); 2003 Dec; 116(12):1854-9. PubMed ID: 14687473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
    Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
    J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice.
    Vidric M; Suh WK; Dianzani U; Mak TW; Watts TH
    J Immunol; 2005 Dec; 175(11):7288-96. PubMed ID: 16301634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses.
    Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS
    J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.
    Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH
    J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.
    Pulle G; Vidric M; Watts TH
    J Immunol; 2006 Mar; 176(5):2739-48. PubMed ID: 16493029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
    Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
    Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential roles of 4-1BB costimulation in HIV type 1 infection.
    Wang S; Kim YJ; Bick C; Kim SH; Kwon BS
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):223-31. PubMed ID: 9491912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors.
    Melero I; Shuford WW; Newby SA; Aruffo A; Ledbetter JA; Hellström KE; Mittler RS; Chen L
    Nat Med; 1997 Jun; 3(6):682-5. PubMed ID: 9176498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
    Martinet O; Divino CM; Zang Y; Gan Y; Mandeli J; Thung S; Pan PY; Chen SH
    Gene Ther; 2002 Jun; 9(12):786-92. PubMed ID: 12040460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.
    Kim YM; Kim HK; Kim HJ; Lee HW; Ju SA; Choi BK; Kwon BS; Kim BS; Kim JB; Lim YT; Yoon S
    Exp Mol Med; 2009 Dec; 41(12):896-911. PubMed ID: 19745604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of costimulatory molecule 4-1BB and CD28 in activating of various T cell subsets from human peripheral blood].
    Wu JY; Qian F; Lu HZ; Wang W; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):533-6. PubMed ID: 15367340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses.
    Kim J; Choi SP; La S; Seo JS; Kim KK; Nam SH; Kwon B
    Exp Mol Med; 2003 Dec; 35(6):509-17. PubMed ID: 14749528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
    Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
    Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.